Decrease in mammary tumour incidence in virgin C3H mice given interferon only while suckling.

por Toliou, T. R., Gabrielides, C. G., Papakyriazis, N., Taylor-Papadimitriou, J.
Publicado 1983

Development of breast cancer immunotherapy using MUC1 retargeted T lymphocytes

por Wilkie, S, Brenner, MK, Taylor-Papadimitriou, J, Burchell, J, Maher, J
Publicado 2006

Understanding and exploiting changes in O-linked glycosylation in breast cancer

por Julien, S, Coleman, J, Picco, G, Beatson, R, Taylor-Papadimitriou, J, Burchell, J
Publicado 2008

PLU-1/Jarid1B contributes to estrogen-induced cell proliferation in the normal mammary gland and in breast cancer, and is required for embryonic survival

por Catchpole, S, Spencer-Dene, B, Hall, D, Scibetta, A, Burchell, J, Taylor-Papadimitriou, J
Publicado 2010

The prognostic value of the monoclonal antibodies HMFG1 and HMFG2 in breast cancer.

por Berry, N., Jones, D. B., Smallwood, J., Taylor, I., Kirkham, N., Taylor-Papadimitriou, J.
Publicado 1985

Immunisation with ‘naïve’ syngeneic dendritic cells protects mice from tumour challenge

por Grimshaw, M J, Papazisis, K, Picco, G, Bohnenkamp, H, Noll, T, Taylor-Papadimitriou, J, Burchell, J
Publicado 2008

Functional analysis of the breast cancer associated transcriptional repressor PLU-1/JARID1B

por Taylor-Papadimitriou, J, Barrett, A, Santangelo, S, Catchpole, S, Coleman, J, Hall, D, Burchell, J, Scibetta, AG
Publicado 2006

Mouse models for pretesting of immunotherapeutic strategies for cancer patients

por Burchell, JM, Miles, DW, Mungul, A, Plunkett, T, Sewell, R, Picco, G, Correa, I, Taylor-Papadimitriou, J
Publicado 2003

A randomised phase II study of sialyl-Tn and DETOX-B adjuvant with or without cyclophosphamide pretreatment for the active specific immunotherapy of breast cancer.

por Miles, D. W., Towlson, K. E., Graham, R., Reddish, M., Longenecker, B. M., Taylor-Papadimitriou, J., Rubens, R. D.
Publicado 1996

Development of breast cancer immunotherapy using MUC1-retargeted T lymphocytes

por Wilkie, S, Picco, G, Foster, J, Davies, D, Julien, S, Cooper, L, Arif, S, Mather, S, Taylor-Papadimitriou, J, Burchell, J, Maher, J
Publicado 2008

A transgenic mouse model for tumour immunotherapy: induction of an anti-idiotype response to human MUC1

por Wilkinson, R W, Ross, E L, Lee-MacAry, A E, Laylor, R, Burchell, J, Taylor-Papadimitriou, J, Snary, D
Publicado 2000

Sialyl-Tn vaccine induces antibody-mediated tumour protection in a relevant murine model

por Julien, S, Picco, G, Sewell, R, Vercoutter-Edouart, A-S, Tarp, M, Miles, D, Clausen, H, Taylor-Papadimitriou, J, Burchell, J M
Publicado 2009

Kinetics, quantitative analysis and radioimmunolocalization using indium-111-HMFG1 monoclonal antibody in patients with breast cancer.

por Kalofonos, H. P., Sackier, J. M., Hatzistylianou, M., Pervez, S., Taylor-Papadimitriou, J., Waxman, J. H., Lavender, J. P., Wood, C., Epenetos, A. A.
Publicado 1989

Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer

por Burford, B, Gentry-Maharaj, A, Graham, R, Allen, D, Pedersen, J W, Nudelman, A S, Blixt, O, Fourkala, E O, Bueti, D, Dawnay, A, Ford, J, Desai, R, David, L, Trinder, P, Acres, B, Schwientek, T, Gammerman, A, Reis, C A, Silva, L, Osório, H, Hallett, R, Wandall, H H, Mandel, U, Hollingsworth, M A, Jacobs, I, Fentiman, I, Clausen, H, Taylor-Papadimitriou, J, Menon, U, Burchell, J M
Publicado 2013